Regulatory Pathway for Licensing Biotherapeutics in Mexico

Biotherapeutic products which are derived from living organisms using recombinant DNA technology significantly contribute to the progress in the treatment of life-threatening and chronic diseases. The worldwide sale of biological drugs in 2016 was near US $263,700 million. In Latin America, where mo...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Morales, Carlos A., Tenorio-Calvo, Alejandra, Cruz-Rodríguez, Rodolfo, Sánchez y Tepoz, Julio, Belgharbi, Lahouari, Pérez-Tapia, Sonia Mayra, Medina-Rivero, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167464/
https://www.ncbi.nlm.nih.gov/pubmed/30320117
http://dx.doi.org/10.3389/fmed.2018.00272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167464/
https://www.ncbi.nlm.nih.gov/pubmed/30320117
http://dx.doi.org/10.3389/fmed.2018.00272

Ejemplares similares